Literature DB >> 32778740

Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK.

Darren Shu Jeng Ting1, Sherine Krause2, Dalia G Said3, Harminder S Dua4.   

Abstract

Entities:  

Year:  2020        PMID: 32778740      PMCID: PMC7417103          DOI: 10.1038/s41433-020-01130-4

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.

To the Editor:

In response to the Coronavirus disease 2019 (or COVID-19) pandemic, many countries across the world, including the UK, had imposed nationwide lockdown. Ophthalmology represents one of the busiest outpatient-based specialties, and cancellation of routine services meant that thousands of eye patients had been affected. Several studies have previously shown that COVID-19 lockdown and quarantine in general could negatively impact on the mental health of adults, children, and healthcare workers [1-3], but the impact of people with eye diseases has not been evaluated. In this survey, we aimed to evaluate the psychosocial impact of COVID-19 lockdown on people living with eye diseases in the UK. In May 2020, a 27-item online questionnaire-based survey was administered to individuals (≥18 years old) with eye diseases (Supplementary Table 1). Participants were identified through various eye support charities or support groups. The level of visual impairment (VI) was categorised into normal/mild, moderate, and severely sight impaired/blind. Statistical analysis was performed using IBM SPSS Statistics v26. Multivariable logistic regression analysis was conducted to determine the predictive factors for worsened mental health, loneliness, and fear of further sight loss during lockdown. Ethical approval of this survey was waived as no medical assessment/intervention was performed. Informed consent for publication was obtained from all participants. Of all 325 respondents, 64.3% were ≥65 years and 71.1% were female (Supplementary Table 2). The level of VI was none/mild (34.8%), moderate (38.2%), severe/blind (24.9%), and unmentioned (8.3%). The lockdown negatively impacted on the mental health (45.9%), loneliness (46.0%), social life (85.3%), anxiety related to hospital visits (55.1%), and fear of further sight loss due to delayed review/treatment (45.9%), amongst others (Fig. 1). In addition, 39.2% respondents mentioned that their eye diseases had made it more difficult to cope with the lockdown. Logistic regression analyses demonstrated that the lockdown had significantly affected the mental health of people who were of 18–64 years (OR 3.16; p < 0.001), and with moderate (OR 2.61; p = 0.001) or severe VI (OR 2.07; p = 0.044; Table 1). People with moderate or severe VI were three times more likely to experience increased loneliness than those with mild/no VI (p < 0.001 and p = 0.002, respectively). Fear of further sight loss was similar across all age groups, gender, and extent of VI (all p > 0.05). The open comments reflected anxiety, stress, and fear impacting on mental health, compounded by the limitations posed by their VI on undertaking routine activities or providing care to other family members.
Fig. 1

Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases.

The questions (Q) asked in each column corresponds with the question number listed in the questionnaire (see Supplementary Table 1). “Strongly agree/agree” means that the respondents agreed that the lockdown had a negative impact on the questioned aspect and vice versa for “strongly disagree/disagree”.

Table 1

Multivariable logistic regression analyses examining the predictive factors for worsened mental health, loneliness, and fear of further sight loss in people living with eye diseases during the COVID-19 pandemic lockdown.

Mental healthOR (95% CI)P valueLonelinessOR (95% CI)P valueFear of sight lossOR (95% CI)P value
Age, years
 18–643.16 (1.81–5.52)<0.0011.30 (0.76–2.23)0.351.00 (0.50–1.99)>0.99
 65 or olderReferenceReferenceReference
Gender
 MaleReferenceReferenceReference
 Female1.44 (0.80–2.59)0.231.60 (0.88–2.91)0.120.91 (0.43–1.94)0.81
Ethnicity
 WhiteReferenceReferenceReference
 BAME0.34 (0.07–1.61)0.180.96 (0.23–3.99)0.961.03 (0.17–6.07)0.98
Extent of sight loss
 Mild or no VIReferenceReferenceReference
 Moderate VI2.61 (1.45–4.70)0.0012.99 (1.69–5.32)<0.0011.10 (0.54–2.26)0.79
 Severe VI or blind2.07 (1.02–4.19)0.0443.02 (1.51–6.07)0.0021.28 (0.51–3.22)0.60

Statistically significant values are underlined.

OR odd ratio, CI confidence interval, BAME Black, Asian and minority ethnicity, VI visual impairment.

Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases.

The questions (Q) asked in each column corresponds with the question number listed in the questionnaire (see Supplementary Table 1). “Strongly agree/agree” means that the respondents agreed that the lockdown had a negative impact on the questioned aspect and vice versa for “strongly disagree/disagree”. Multivariable logistic regression analyses examining the predictive factors for worsened mental health, loneliness, and fear of further sight loss in people living with eye diseases during the COVID-19 pandemic lockdown. Statistically significant values are underlined. OR odd ratio, CI confidence interval, BAME Black, Asian and minority ethnicity, VI visual impairment. Sight loss is a big health concern, and delay in follow-up and care could result in significant and/or permanent harm to vision [4]. We highlighted that COVID-19 lockdown could pose a significant negative psychosocial impact on people with VI. It is therefore important to recognise and provide additional psychosocial support to this vulnerable group of people during the pandemic [3]. COVID-19 pandemic has posed challenges but also presented new opportunities. In view of the significant backlog of work and ongoing social distancing measures, adoption of telemedicine in ophthalmology will likely become the new “norm” of ophthalmology during and after the pandemic [5]. Supplementary Table 1 Supplementary Table 2
  1 in total

1.  Detection of features associated with neovascular age-related macular degeneration in ethnically distinct data sets by an optical coherence tomography: trained deep learning algorithm.

Authors:  Aaron Y Lee; Tyler Hyungtaek Rim; Daniel S Ting; Kelvin Teo; Bjorn Kaijun Betzler; Zhen Ling Teo; Tea Keun Yoo; Geunyoung Lee; Youngnam Kim; Andrew C Lin; Seong Eun Kim; Yih Chung Tham; Sung Soo Kim; Ching-Yu Cheng; Tien Yin Wong; Chui Ming Gemmy Cheung
Journal:  Br J Ophthalmol       Date:  2020-09-09       Impact factor: 4.638

  1 in total
  14 in total

1.  Differences in Unfavorable Lifestyle Changes during the COVID-19 Pandemic between People with and without Disabilities in Finland: Psychological Distress as a Mediator.

Authors:  Marja Eliisa Holm; Päivi Sainio; Jaana Suvisaari; Katri Sääksjärvi; Tuija Jääskeläinen; Suvi Parikka; Seppo Koskinen
Journal:  Int J Environ Res Public Health       Date:  2022-06-07       Impact factor: 4.614

2.  Impact of the COVID-19 pandemic on individuals with nystagmus and an exploration of public assumptions about the condition: an electronic questionnaire study.

Authors:  Katherine Rennie; Rajeeth Alagendran; Helena Lee; Helen Griffiths; James Self
Journal:  BMC Ophthalmol       Date:  2022-06-20       Impact factor: 2.086

3.  The Impact of Three Waves of the COVID-19 Pandemic on the Characteristics of Primary Rhegmatogenous Retinal Detachments at a Tertiary Referral Centre.

Authors:  Diana Dmuchowska; Izabela Cwalina; Pawel Krasnicki; Joanna Konopinska; Emil Saeed; Zofia Mariak; Iwona Obuchowska
Journal:  Clin Ophthalmol       Date:  2021-08-16

4.  Comment on: The Impact of COVID-19 on Individuals Across the Spectrum of Visual Impairment.

Authors:  Darren Shu Jeng Ting; Sherine Krause; Dalia G Said; Harminder S Dua
Journal:  Am J Ophthalmol       Date:  2021-05-11       Impact factor: 5.488

5.  The impact of COVID-19 pandemic on ophthalmology services: are we ready for the aftermath?

Authors:  Darren Shu Jeng Ting; Rashmi Deshmukh; Dalia G Said; Harminder S Dua
Journal:  Ther Adv Ophthalmol       Date:  2020-10-20

6.  Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update.

Authors:  Jean-François Korobelnik; Anat Loewenstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-07       Impact factor: 3.117

Review 7.  Diagnostic armamentarium of infectious keratitis: A comprehensive review.

Authors:  Darren S J Ting; Bhavesh P Gopal; Rashmi Deshmukh; Gerami D Seitzman; Dalia G Said; Harminder S Dua
Journal:  Ocul Surf       Date:  2021-11-13       Impact factor: 5.033

8.  Smartphone-based remote monitoring of vision in macular disease enables early detection of worsening pathology and need for intravitreal therapy.

Authors:  Meriam Islam; Stafford Sansome; Radha Das; Marko Lukic; Kelvin Yi Chong Teo; Gavin Tan; Konstantinos Balaskas; Peter B M Thomas; Lucas M Bachmann; Andrew M Schimel; Dawn A Sim
Journal:  BMJ Health Care Inform       Date:  2021-05

9.  Implementation of a new telephone triage system in ophthalmology emergency department during COVID-19 pandemic: clinical effectiveness, safety and patient satisfaction.

Authors:  Yunzi Chen; Rehab Ismail; Muhammad R Cheema; Darren S J Ting; Ibrahim Masri
Journal:  Eye (Lond)       Date:  2021-05-25       Impact factor: 4.456

10.  A Real-World Single-Centre Study of Patients with Diabetic Macular Oedema Who Wore a Home-Use Sleep Mask (Noctura 400) for One Year.

Authors:  Ulrich Meyer-Bothling; Oliver Meyer-Bothling; Marika Pinney
Journal:  J Ophthalmol       Date:  2021-06-15       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.